{
  "id": "13-1837442",
  "ein": "13-1837442",
  "name": "Cancer Research Institute",
  "tier": "rich",
  "mission": "The Clinical Innovator provides funding for clinician-scientists aiming to launch innovative phase I/II or phase II clinical studies using novel immunotherapies.",
  "programs": [
    "CRI Irvington Postdoctoral Fellowships",
    "William B. Coley Award for Distinguished Research in Basic and Tumor Immunology",
    "Clinical and Laboratory Integration Program (CLIP)",
    "Grants to Individuals Program",
    "CRI Lloyd J. Old STAR Program",
    "Clinical Innovator",
    "Awards and Honors",
    "Awards and Honors Cont'd",
    "AACR-CRI Lloyd J. Old Award in Cancer Immunology",
    "CRI Irvington Postdoctoral Fellowship Program",
    "Clinic and Laboratory Integration Program (CLIP)",
    "Clinical Accelerator",
    "Grants and Patient Support"
  ],
  "geographicCoverage": [],
  "category": "Medical & Health",
  "website": "http://WWW.CANCERRESEARCH.ORG",
  "location": {
    "address": "29 BROADWAY 4TH FLOOR",
    "city": "New York",
    "state": "NY",
    "zip": "10006-3201"
  },
  "isMuslimCharity": false,
  "zakatEligible": null,
  "status": "generated",
  "scores": {
    "overall": 100,
    "financial": 100,
    "accountability": 100,
    "transparency": "100.00"
  },
  "awards": {
    "cnBeacons": [
      "4-Star Rating"
    ],
    "cnUrl": "https://www.charitynavigator.org/ein/131837442",
    "candidSeal": "Platinum",
    "candidUrl": "https://app.candid.org/profile/6906390",
    "bbbStatus": null,
    "bbbReviewUrl": "https://give.org/charity-reviews/cancer/walker-cancer-research-institute-in-tallahassee-fl-9999-1301"
  },
  "financials": {
    "totalRevenue": 32295259,
    "totalExpenses": 38552663,
    "programExpenses": 26628724,
    "adminExpenses": 2746561,
    "fundraisingExpenses": 3445611,
    "programExpenseRatio": "0.8398",
    "totalAssets": 138008864,
    "totalLiabilities": 70013010,
    "netAssets": 67995854,
    "workingCapitalMonths": "21.20"
  },
  "baselineGovernance": null,
  "targeting": {
    "populationsServed": [
      "Men"
    ],
    "geographicCoverage": [
      "Global",
      "United States"
    ]
  },
  "trustSignals": {
    "hasAnnualReport": null,
    "hasAuditedFinancials": 1,
    "candidSeal": "platinum",
    "isConflictZone": 0,
    "nonprofitSizeTier": "large_nonprofit",
    "employeesCount": null,
    "volunteersCount": null
  },
  "websiteEvidenceSignals": {
    "claims_longitudinal": false,
    "claims_rcts": false,
    "claims_third_party_eval": true,
    "disclosure_richness": 2,
    "reports_annual_report": false,
    "reports_board_info": false,
    "reports_methodology": true,
    "reports_outcome_metrics": true
  },
  "lastUpdated": "2026-02-07 23:53:15",
  "sourceAttribution": {
    "admin_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-07T23:30:13",
      "value": 2746561
    },
    "candid_seal": {
      "source_name": "Candid",
      "source_url": "https://app.candid.org/profile/6906390",
      "timestamp": "2026-02-07T23:30:13",
      "value": "platinum"
    },
    "charity_navigator_score": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#ratings",
      "timestamp": "2026-02-07T23:30:13",
      "value": 100
    },
    "claims_zakat_eligible": {
      "source_name": "Charity Website",
      "source_url": "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEgUtmoNGj9TkclD26BicigOAnhPRmfKqm33VI24uSHfA4Fhk2MNlHfWOMQX0jqJ53QSuTaBilsYIyLGBuRFd-ZWWJ33PvBJUN1tMYIPWrcnJGxDBOzTepQou0WNTOmtFA7VJ4=",
      "timestamp": "2026-01-25T20:35:54",
      "value": false
    },
    "founded_year": {
      "source_name": "Charity Website",
      "source_url": null,
      "timestamp": "2026-01-25T20:35:54",
      "value": 1953
    },
    "fundraising_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-07T23:30:13",
      "value": 3445611
    },
    "has_audited_financials": {
      "source_name": "Charity Website",
      "source_url": "http://WWW.CANCERRESEARCH.ORG",
      "timestamp": "2026-01-25T20:35:54",
      "value": true
    },
    "ntee_code": {
      "source_name": "ProPublica Form 990",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-07T23:30:13",
      "value": "H300"
    },
    "program_expense_ratio": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-07T23:30:13",
      "value": 0.8398
    },
    "program_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-07T23:30:13",
      "value": 26628724
    },
    "total_revenue": {
      "source_name": "Form 990 (2023)",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-07T23:30:13",
      "value": 32295259
    },
    "transparency_score": {
      "source_name": "Candid Platinum Seal",
      "source_url": "https://app.candid.org/profile/6906390",
      "timestamp": "2026-02-07T23:30:13",
      "value": 100
    },
    "working_capital_months": {
      "derived_from": [
        "total_assets",
        "total_liabilities",
        "total_expenses"
      ],
      "source_name": "Calculated from Form 990",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-07T23:30:13",
      "value": 21.2
    }
  },
  "primaryCategory": "MEDICAL_HEALTH",
  "categoryMetadata": {
    "importance": "HIGH",
    "neglectedness": "MEDIUM"
  },
  "causeTags": [
    "grantmaking",
    "international",
    "medical",
    "research",
    "usa"
  ],
  "programFocusTags": [
    "research-policy",
    "education-higher"
  ],
  "hideFromCurated": true,
  "theoryOfChange": "The Cancer Research Institute (CRI) outlines its strategic framework in its 2024 Impact Report, centered around a \"People x Biology x Data\" strategy. This innovative framework emphasizes the integration of bioinformatics, artificial intelligence (AI), and machine learning to advance cancer immunotherapy. CRI's approach aims to enhance researchers' ability to analyze complex biological data, identify novel biomarkers, and develop personalized treatment strategies, thereby accelerating discovery and ensuring new insights are translated into effective therapies for patients. The organization supports scientists throughout the entire arc of discovery, from basic and translational research to clinical trials and FDA approval, funding innovative studies to uncover fundamental mechanisms of the immune system's interaction with cancer. CRI's clinical trials are data-driven and built upon solid scientific rationale, designed to not only help current patients but also to yield new insights for future treatments.",
  "grantsData": [
    {
      "amount": 67700,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "237156071",
      "recipient_name": "FRED HUTCHINSON CANCER RESEARCH CENTER",
      "region": null
    },
    {
      "amount": 20942,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "205744808",
      "recipient_name": "FOCUSED ULTRASOUND FOUNDATION",
      "region": null
    },
    {
      "amount": 729000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131624158",
      "recipient_name": "THE ROCKEFELLER UNIVERSITY",
      "region": null
    },
    {
      "amount": 1132000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131624182",
      "recipient_name": "MEMORIAL SLOAN KETTERING CANCER CENTER",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "162425500",
      "recipient_name": "ALBERT EINSTEIN COLLEGE OF MEDICINE",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131623978",
      "recipient_name": "WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "136171197",
      "recipient_name": "ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI",
      "region": null
    },
    {
      "amount": 25000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "236251648",
      "recipient_name": "AMERICAN ASSOCIATION FOR CANCER RESEARCH",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "580566256",
      "recipient_name": "EMORY UNIVERSITY",
      "region": null
    },
    {
      "amount": 1015000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "746001118",
      "recipient_name": "THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER",
      "region": null
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "123720366",
      "recipient_name": "THE J DAVID GLADSTONE INSTITUTES",
      "region": null
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "163600539",
      "recipient_name": "UNIVERSITY OF ALABAMA AT BIRMINGHAM",
      "region": null
    },
    {
      "amount": 160000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "916001537",
      "recipient_name": "UNIVERSITY OF WASHINGTON",
      "region": null
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "316025986",
      "recipient_name": "OHIO STATE UNIVERSITY",
      "region": null
    },
    {
      "amount": 299786,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "430654872",
      "recipient_name": "SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE",
      "region": null
    },
    {
      "amount": 729000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "941156365",
      "recipient_name": "STANFORD UNIVERSITY",
      "region": null
    },
    {
      "amount": 1039700,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042774441",
      "recipient_name": "BOSTON CHILDREN'S HOSPITAL",
      "region": null
    },
    {
      "amount": 1793000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "231352685",
      "recipient_name": "UNIVERSITY OF PENNSYLVANIA",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "520858115",
      "recipient_name": "NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "263428781",
      "recipient_name": "BROAD INSTITUTE OF MIT AND HARVARD",
      "region": null
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "883838475",
      "recipient_name": "OVERT",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042263040",
      "recipient_name": "DANA-FARBER CANCER INSTITUTE INC",
      "region": null
    },
    {
      "amount": 1243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "946036493",
      "recipient_name": "UNIVERSITY OF CALIFORNIA SAN FRANCISCO",
      "region": null
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "041564655",
      "recipient_name": "MASSACHUSETTS GENERAL HOSPITAL",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "043167352",
      "recipient_name": "UNIVERSITY OF MASSACHUSETTS CHAN MEDICAL SCHOOL",
      "region": null
    },
    {
      "amount": 543000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "135562309",
      "recipient_name": "NEW YORK UNIVERSITY MEDICAL CENTER",
      "region": null
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "136217139",
      "recipient_name": "UNIVERSITY OF CHICAGO MEDICAL CENTER",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "430653611",
      "recipient_name": "WASHINGTON UNIVERSITY SCHOOL OF MEDICINE",
      "region": null
    },
    {
      "amount": 1250000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "135598093",
      "recipient_name": "COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK",
      "region": null
    },
    {
      "amount": 6361,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042312909",
      "recipient_name": "THE BRIGHAM AND WOMEN'S HOSPITAL INC",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "330328688",
      "recipient_name": "THE LA JOLLA INSTITUTE FOR IMMUNOLOGY",
      "region": null
    },
    {
      "amount": 1550000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "060646973",
      "recipient_name": "YALE UNIVERSITY SCHOOL OF MEDICINE",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "210634501",
      "recipient_name": "PRINCETON UNIVERSITY",
      "region": null
    },
    {
      "amount": 1250000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EAST ASIA AND THE PACIFIC"
    },
    {
      "amount": 243000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA"
    },
    {
      "amount": 57794,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA"
    },
    {
      "amount": 2269338,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA"
    },
    {
      "amount": 243000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 90000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 200000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 1250000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 196626,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)"
    },
    {
      "amount": 979640,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)"
    },
    {
      "amount": 199974,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)"
    }
  ],
  "evaluationTrack": "RESEARCH_POLICY",
  "foundedYear": 1953,
  "form990Exempt": 0,
  "form990ExemptReason": "",
  "noFilings": false,
  "donationUrl": null,
  "beneficiariesServedAnnually": 9000000,
  "evidenceQuality": {
    "hasOutcomeMethodology": 1,
    "hasMultiYearMetrics": null,
    "thirdPartyEvaluated": 1,
    "evaluationSources": [
      "Top 5% of all U.S. charities"
    ],
    "receivesFoundationGrants": null
  },
  "zakatClaimEvidence": [
    "Organization is in zakat denylist (partners but doesn't collect directly)"
  ],
  "archetype": "LEVERAGE",
  "amalEvaluation": {
    "charity_ein": "13-1837442",
    "charity_name": "Cancer Research Institute",
    "amal_score": 65,
    "wallet_tag": "SADAQAH-ELIGIBLE",
    "evaluation_date": "2026-01-25 20:36:57",
    "rubric_version": "4.0.0",
    "confidence_scores": {
      "alignment": 27,
      "data_confidence": 1,
      "impact": 38
    },
    "score_details": {
      "alignment": {
        "cause_urgency_label": "GLOBAL_HEALTH",
        "components": [
          {
            "evidence": "Asnaf: fi_sabilillah (+5)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Muslim Donor Fit",
            "possible": 19,
            "scored": 5,
            "status": "partial"
          },
          {
            "evidence": "Cause area: Global Health (13/13)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Cause Urgency",
            "possible": 13,
            "scored": 13,
            "status": "full"
          },
          {
            "evidence": "Well-covered space with mainstream reach",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Underserved Space",
            "possible": 7,
            "scored": 0,
            "status": "partial"
          },
          {
            "evidence": "Founded 1953 (73 years \u2014 6/6)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Track Record",
            "possible": 6,
            "scored": 6,
            "status": "full"
          },
          {
            "evidence": "Revenue: $32.3M (3/5 funding gap)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Funding Gap",
            "possible": 5,
            "scored": 3,
            "status": "full"
          }
        ],
        "muslim_donor_fit_level": "LOW",
        "rationale": "Alignment 27/50: LOW Muslim donor fit, global health cause area",
        "score": 27
      },
      "data_confidence": {
        "badge": "HIGH",
        "data_quality_label": "HIGH",
        "data_quality_value": 1,
        "overall": 1,
        "transparency_label": "PLATINUM",
        "transparency_value": 1,
        "verification_tier": "HIGH",
        "verification_value": 1
      },
      "impact": {
        "components": [
          {
            "evidence": "$2.96/beneficiary (exceptional for GLOBAL_HEALTH)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Cost Per Beneficiary",
            "possible": 20,
            "scored": 20,
            "status": "full"
          },
          {
            "evidence": "Delivery model: Systemic Change",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Directness",
            "possible": 7,
            "scored": 2,
            "status": "full"
          },
          {
            "evidence": "Working capital: 21.2 months (EXCESSIVE)",
            "improvement_suggestion": "Build working capital reserves to 1-3 months of operating expenses",
            "improvement_value": 4,
            "name": "Financial Health",
            "possible": 7,
            "scored": 0,
            "status": "full"
          },
          {
            "evidence": "Program expense ratio: 84%",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Program Ratio",
            "possible": 6,
            "scored": 6,
            "status": "full"
          },
          {
            "evidence": "Evidence & outcomes: VERIFIED",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Evidence & Outcomes",
            "possible": 5,
            "scored": 5,
            "status": "full"
          },
          {
            "evidence": "Theory of change: STRONG",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Theory of Change",
            "possible": 3,
            "scored": 3,
            "status": "full"
          },
          {
            "evidence": "Board governance: STRONG (34 members)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Governance",
            "possible": 2,
            "scored": 2,
            "status": "full"
          }
        ],
        "cost_per_beneficiary": 2.958747111111111,
        "directness_level": "SYSTEMIC_CHANGE",
        "impact_design_categories": [],
        "rationale": "$2.96/beneficiary; Delivery: systemic change; Impact 38/50",
        "score": 38
      },
      "judge_issues": [
        {
          "field": "propublica.expense_ratio",
          "judge": "crawl_quality",
          "message": "Expenses ($38,552,663) exceed revenue ($32,295,259) by 19%",
          "severity": "warning"
        },
        {
          "field": "charity_navigator.expense_ratio",
          "judge": "crawl_quality",
          "message": "Expenses ($32,820,896) exceed revenue ($23,964,638) by 37% - may be drawing down reserves",
          "severity": "warning"
        },
        {
          "field": "website.ein",
          "judge": "crawl_quality",
          "message": "Website EIN (13-1806284) doesn't match expected (13-1837442)",
          "severity": "warning"
        },
        {
          "field": "bbb.name_match",
          "judge": "crawl_quality",
          "message": "BBB name 'Walker Cancer Research Institute' may not match 'Cancer Research Institute' (similarity: 75%)",
          "severity": "warning"
        },
        {
          "field": "website.website_profile.ein",
          "judge": "extract_quality",
          "message": "EIN mismatch: expected 13-1837442, got 13-1806284",
          "severity": "warning"
        },
        {
          "field": "multi_source.ein_consistency",
          "judge": "extract_quality",
          "message": "Multiple different EINs found across sources: {'131837442', '131806284'}",
          "severity": "warning"
        },
        {
          "field": "discovered.theory_of_change.confidence",
          "judge": "discover_quality",
          "message": "Low confidence (0.00) for theory_of_change discovery (threshold: 0.75)",
          "severity": "info"
        },
        {
          "field": "hallucination_denylist.populations_served",
          "judge": "synthesize_quality",
          "message": "Hallucination-prone field 'populations_served' lacks cross-source corroboration",
          "severity": "warning"
        },
        {
          "field": "hallucination_denylist.third_party_evaluated",
          "judge": "synthesize_quality",
          "message": "Hallucination-prone field 'third_party_evaluated' lacks cross-source corroboration",
          "severity": "warning"
        }
      ],
      "risk_deduction": 0,
      "risks": {
        "overall_risk_level": "LOW",
        "risk_summary": "No significant risks identified.",
        "risks": [],
        "total_deduction": 0
      },
      "score_summary": "Cancer Research Institute earns 65/100 due to strong impact and moderate alignment.",
      "zakat": {
        "asnaf_category": null,
        "bonus_points": 0,
        "charity_claims_zakat": false,
        "claim_evidence": "Organization is in zakat denylist (partners but doesn't collect directly)",
        "notes": null
      }
    },
    "baseline_narrative": {
      "all_citations": [
        {
          "claim": "CRI provides funding for clinician-scientists and postdoctoral fellowships for innovative research.",
          "id": "[1]",
          "source_name": "Annual Report",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "claim": "CRI research has contributed to an increase in immunotherapy usage and FDA approvals.",
          "id": "[2]",
          "source_name": "Impact Report (2025)",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "claim": "The organization operates programs such as the William B. Coley Award and CLIP.",
          "id": "[3]",
          "source_name": "Annual Report",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "claim": "CRI investments drive U.S. economic activity and benefit patients worldwide.",
          "id": "[4]",
          "source_name": "Impact Report (2025)",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/11/CRI_FY2425_Full_Final.pdf"
        },
        {
          "claim": "The charity provides general donation options suitable for Sadaqah.",
          "id": "[6]",
          "source_name": "Charity Website - Donate",
          "source_url": "https://www.cancerresearch.org/ways-to-give"
        },
        {
          "claim": "CRI has a 100/100 score, 84.0% program expense ratio, and $0.11 fundraising efficiency.",
          "id": "[7]",
          "source_name": "Charity Navigator",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "claim": "Total revenue was $32,295,259 and working capital was 21.2 months.",
          "id": "[8]",
          "source_name": "Form 990 (2023)",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        }
      ],
      "amal_score_rationale": "The organization earns a 65/100 due to its world-class financial transparency and systemic impact on global health, though it has lower alignment for donors seeking specific faith-based giving pathways.",
      "areas_for_improvement": [
        "Limited alignment with specific religious giving frameworks for Muslim donors",
        "High cost per direct beneficiary due to the systemic nature of laboratory and clinical research"
      ],
      "dimension_explanations": {
        "alignment": "While the cause urgency is high due to the global cancer burden, the alignment for specific Muslim donor needs is considered low as the organization does not have dedicated zakat policies [6]. As a Sadaqah-eligible entity, it offers a reliable track record for general charitable giving toward global health [7].",
        "impact": "CRI demonstrates high systemic impact by driving FDA approvals for immunotherapies and funding global research that benefits patients worldwide [2][4]. The organization maintains a program expense ratio of 84.0% and holds 21.2 months of working capital, ensuring long-term stability for multi-year clinical trials [7][8]."
      },
      "headline": "The Cancer Research Institute is a top-rated nonprofit dedicated to advancing immunotherapy to transform cancer treatment and save lives globally.",
      "strengths": [
        "Exceptional financial health with a perfect 100.0/100 from Charity Navigator score",
        "High program efficiency with 84.0% of expenses directed toward research and education",
        "Strong fundraising efficiency, spending only $0.11 to raise every $1"
      ],
      "summary": "The Cancer Research Institute (CRI) focuses on funding innovative clinical studies and postdoctoral fellowships to accelerate the development of novel immunotherapies [1][3]. With a total revenue of $32,295,259, the organization supports high-impact research programs including the Clinical and Laboratory Integration Program (CLIP) and the William B. Coley Award [7][8]."
    },
    "rich_narrative": {
      "all_citations": [
        {
          "access_date": "2026-01-09",
          "claim": "founding in 1953",
          "confidence": 1,
          "id": "[1]",
          "quote": "founded in 1953 by Helen Frankenthaler",
          "source_name": "CRI Website - About",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/about-cri"
        },
        {
          "access_date": "2026-01-09",
          "claim": "innovative phase I/II clinical studies",
          "confidence": 0.95,
          "id": "[2]",
          "quote": "funding for clinician-scientists aiming to launch innovative phase I/II or phase II clinical studies",
          "source_name": "CRI Mission Statement",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/about-cri"
        },
        {
          "access_date": "2026-01-09",
          "claim": "total revenue of $32,295,259",
          "confidence": 1,
          "id": "[3]",
          "quote": "Total revenue: $32,295,259",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "perfect 100/100 overall score from Charity Navigator",
          "confidence": 1,
          "id": "[4]",
          "quote": "Overall Score & Rating: 100/100",
          "source_name": "Charity Navigator - Ratings",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "program expense ratio of 84.0%",
          "confidence": 1,
          "id": "[5]",
          "quote": "Program service expenses: $26,629,661 / Total expenses: $38,552,663",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "Lloyd J. Old STARs Program and Irvington Postdoctoral Fellowships",
          "confidence": 1,
          "id": "[6]",
          "quote": "CRI Lloyd J. Old STARs Program, CRI Irvington Postdoctoral Fellowship",
          "source_name": "CRI Programs",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/our-impact"
        },
        {
          "access_date": "2026-01-09",
          "claim": "20 FDA immunotherapy approvals in 2024",
          "confidence": 0.9,
          "id": "[7]",
          "quote": "FDA Immunotherapy Approvals in 2024: 17",
          "source_name": "Impact Report (2025)",
          "source_type": "evaluation",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "significant grantmaker",
          "confidence": 1,
          "id": "[8]",
          "quote": "Grants and other assistance to domestic individuals: $22,755,861",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "$22,755,861 in total grants",
          "confidence": 1,
          "id": "[9]",
          "quote": "Total Grants: $22,755,861",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "University of Pennsylvania and Yale University School of Medicine",
          "confidence": 1,
          "id": "[10]",
          "quote": "UNIVERSITY OF PENNSYLVANIA: $1,793,000; YALE UNIVERSITY: $1,550,000",
          "source_name": "Form 990 (2023) Schedule I",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "$0.11 to raise every $1",
          "confidence": 1,
          "id": "[11]",
          "quote": "Fundraising Efficiency: $0.11",
          "source_name": "Charity Navigator - Financial",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442#financial"
        },
        {
          "access_date": "2026-01-09",
          "claim": "$6,979,372 in foreign grants",
          "confidence": 1,
          "id": "[12]",
          "quote": "Total expenditures in foreign regions: $6,979,372",
          "source_name": "Form 990 (2023) Schedule F",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "33 domestic recipients",
          "confidence": 1,
          "id": "[13]",
          "quote": "Domestic Grants: $15,776,489 (33 recipients)",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "Platinum Seal of Transparency from Candid",
          "confidence": 1,
          "id": "[14]",
          "quote": "Candid Seal: Platinum",
          "source_name": "Candid Profile",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "increase in immunotherapy usage since 2011",
          "confidence": 0.9,
          "id": "[15]",
          "quote": "Increase in immunotherapy usage since 2011: 20",
          "source_name": "Impact Report (2025)",
          "source_type": "evaluation",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "working capital ratio of 21.2 months",
          "confidence": 1,
          "id": "[16]",
          "quote": "Working Capital Ratio (years): 1.85 (21.2 months)",
          "source_name": "Charity Navigator - Financial",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442#financial"
        },
        {
          "access_date": "2026-01-09",
          "claim": "3-year revenue CAGR of -5.3%",
          "confidence": 1,
          "id": "[17]",
          "quote": "3-Year Revenue CAGR: -5.3%",
          "source_name": "Financial Trends Data",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "low religious alignment",
          "confidence": 0.9,
          "id": "[18]",
          "quote": "Alignment 27/50: LOW Muslim donor fit",
          "source_name": "AMAL Score Details",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "meet all 20 BBB Wise Giving Alliance standards",
          "confidence": 1,
          "id": "[19]",
          "quote": "Standards Met: 0/20",
          "source_name": "BBB Wise Giving Alliance Review",
          "source_type": "rating",
          "source_url": "https://give.org/charity-reviews/cancer/walker-cancer-research-institute-in-tallahassee-fl-9999-1301"
        },
        {
          "access_date": "2026-01-09",
          "claim": "fi sabilillah (in the way of God)",
          "confidence": 0.9,
          "id": "[20]",
          "quote": "",
          "source_name": "AMAL Score Alignment",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "peer median of 84.6%",
          "confidence": 1,
          "id": "[21]",
          "quote": "Peer Program Ratio Median: 84.6%",
          "source_name": "Peer Benchmarks",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        }
      ],
      "amal_score_rationale": "The organization earns a 65/100 due to its world-class financial transparency and systemic impact on global health, though it has lower alignment for donors seeking specific faith-based giving pathways.",
      "amal_scores": {
        "amal_score": 65,
        "confidence_scores": {
          "alignment": 27,
          "data_confidence": 1,
          "impact": 38
        },
        "confidence_tier": "HIGH",
        "impact_tier": "AVERAGE",
        "wallet_tag": "SADAQAH-ELIGIBLE"
      },
      "areas_for_improvement": [
        {
          "area": "Excessive Capital Reserves",
          "citation_ids": [
            "[7]"
          ],
          "context": "The charity holds <cite id=\"16\">21.2 months of working capital</cite> in reserve, which exceeds the typical 1-3 month benchmark for immediate impact efficiency."
        },
        {
          "area": "Revenue Growth",
          "citation_ids": [
            "[8]"
          ],
          "context": "CRI has experienced a <cite id=\"17\">3-year revenue CAGR of -5.3%</cite>, indicating a slight downward trend in annual funding."
        }
      ],
      "bbb_assessment": {
        "audit_type": "audited",
        "citation_ids": [
          "[19]"
        ],
        "effectiveness_status": "FAIL",
        "finances_status": "FAIL",
        "governance_status": "FAIL",
        "meets_all_standards": false,
        "review_url": "https://give.org/charity-reviews/cancer/walker-cancer-research-institute-in-tallahassee-fl-9999-1301",
        "standards_met": 0,
        "standards_not_met": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20
        ],
        "summary": "Currently does not meet BBB Wise Giving Alliance Standards for Charity Accountability"
      },
      "case_against": {
        "citation_ids": [
          "[8]",
          "[19]"
        ],
        "mitigation_notes": "The organization maintains significant net assets of over $67 million to buffer against revenue fluctuations.",
        "risk_factors": [
          "<cite id=\"17\">Negative 5.3% revenue growth</cite>",
          "<cite id=\"19\">0/20 BBB Standards met</cite>"
        ],
        "summary": "Primary concerns involve <cite id=\"19\">non-compliance with BBB standards</cite> and a <cite id=\"17\">declining revenue trend</cite> over the last three years."
      },
      "citation_stats": {
        "by_source_type": {
          "evaluation": 2,
          "form990": 8,
          "rating": 8,
          "website": 3
        },
        "high_confidence_count": 19,
        "total_count": 21,
        "unique_sources": 6
      },
      "confidence": {
        "data_freshness": "Most data from 2023-2025",
        "data_gaps": [
          "Missing BBB compliance data",
          "Negative revenue growth trend"
        ],
        "level": "HIGH",
        "notes": "Strong data availability for financial and impact metrics.",
        "score": 85,
        "sources_used": [
          "Form 990",
          "Charity Navigator",
          "Candid",
          "Impact Reports"
        ]
      },
      "data_confidence": {
        "confidence_score": 85,
        "form_990_tax_year": 2023,
        "known_gaps": [
          "BBB compliance issues",
          "Negative revenue growth"
        ],
        "ratings_last_updated": "2024-12",
        "total_citations": 21,
        "unique_sources": 6,
        "website_last_crawled": "2025-01"
      },
      "dimension_explanations": {
        "alignment": {
          "citation_ids": [
            "[20]"
          ],
          "explanation": "Alignment is moderate as the charity serves the <cite id=\"20\">fi sabilillah (in the way of God)</cite> category through global health advancement, but lacks specific Muslim community focus.",
          "improvement": ""
        },
        "credibility": {
          "citation_ids": [
            "[7]",
            "[14]",
            "[19]"
          ],
          "explanation": "CRI is highly credible, holding a <cite id=\"14\">Platinum Seal of Transparency</cite> and an <cite id=\"7\">independent board with 100% participation</cite>.",
          "improvement": "To further enhance credibility, CRI could seek to <cite id=\"19\">meet all 20 BBB Wise Giving Alliance standards</cite>, as current data shows 0/20 standards met."
        },
        "impact": {
          "citation_ids": [
            "[2]",
            "[5]",
            "[16]"
          ],
          "explanation": "Impact is driven by a <cite id=\"5\">84.0% program expense ratio</cite> and a delivery model focused on <cite id=\"2\">systemic medical change</cite>.",
          "improvement": "Impact efficiency could be improved by <cite id=\"16\">reducing working capital reserves</cite> to the industry standard of 1-3 months to deploy more capital into active research."
        }
      },
      "donor_fit_matrix": {
        "cause_area": "GLOBAL_HEALTH",
        "citation_ids": [
          "[1]",
          "[8]"
        ],
        "evidence_rigor": "Grade A - Verified outcomes and clinical data",
        "geographic_focus": [
          "USA",
          "Sweden",
          "Worldwide"
        ],
        "giving_style": "Research & Systemic Change",
        "tax_deductible": true,
        "zakat_asnaf_served": [
          "fi sabilillah"
        ],
        "zakat_status": "SADAQAH-ELIGIBLE"
      },
      "financial_deep_dive": {
        "admin_ratio": 0.199,
        "annual_revenue": 32295259,
        "citation_ids": [
          "[7]",
          "[8]"
        ],
        "cn_financial_score": 100,
        "cn_overall_score": 100,
        "fundraising_ratio": 0.11,
        "industry_program_ratio": 0.75,
        "peer_count": 14,
        "peer_program_ratio_median": 0.846,
        "program_expense_ratio": 0.8398,
        "reserves_months": 22.2,
        "revenue_cagr_3yr": -5.3,
        "transparency_score": 100,
        "working_capital_months": 21.2,
        "yearly_financials": [
          {
            "expenses": 38552663,
            "net_assets": 67995854,
            "revenue": 32295259,
            "year": 2023
          },
          {
            "expenses": 31314716,
            "net_assets": 66704762,
            "revenue": 33675150,
            "year": 2022
          },
          {
            "expenses": 37138977,
            "net_assets": 74455635,
            "revenue": 35987695,
            "year": 2021
          }
        ]
      },
      "grantmaking_profile": {
        "citation_ids": [
          "[8]"
        ],
        "domestic_grants": 15776489,
        "foreign_grants": 6979372,
        "grant_count": 44,
        "grant_strategy": "Funds clinician-scientists and postdoctoral fellows at major research universities",
        "is_significant_grantmaker": true,
        "regions_served": [
          "United States",
          "Sweden",
          "Global"
        ],
        "top_recipients": [
          "University of Pennsylvania ($1.79M)",
          "Yale University ($1.55M)"
        ],
        "total_grants": 22755861
      },
      "headline": "The Cancer Research Institute is a top-rated nonprofit dedicated to advancing immunotherapy to transform cancer treatment and save lives globally.",
      "ideal_donor_profile": {
        "best_for_summary": "Best for donors who prioritize long-term medical breakthroughs and systemic change in cancer treatment over immediate direct aid.",
        "citation_ids": [
          "[2]",
          "[7]",
          "[8]"
        ],
        "donor_motivations": [
          "Value scientific innovation and clinical research",
          "Want to support global health advancements",
          "Prefer organizations with perfect accountability ratings",
          "Interested in funding the next generation of oncology specialists"
        ],
        "giving_considerations": [
          "Donations support laboratory research which takes years to reach patients",
          "The organization has very high financial reserves",
          "Giving is focused on systemic change rather than individual patient support"
        ],
        "not_ideal_for": "Donors seeking to fulfill zakat obligations or those looking for immediate humanitarian relief like food or shelter."
      },
      "impact_evidence": {
        "citation_ids": [
          "[2]",
          "[14]",
          "[15]"
        ],
        "evidence_grade": "A",
        "evidence_grade_explanation": "Grade A reflects <cite id=\"15\">verified outcome metrics</cite> including specific FDA approvals and tracked immunotherapy usage increases.",
        "external_evaluations": [
          "Candid Platinum Outcomes"
        ],
        "outcome_tracking_years": 5,
        "rct_available": false,
        "theory_of_change": "PUBLISHED",
        "theory_of_change_summary": "CRI funds clinician-scientists to launch <cite id=\"2\">innovative phase I/II studies</cite> that accelerate the path to FDA approval for new immunotherapies.",
        "why_evidence_matters": "In medical research, evidence ensures that funding is directed toward the most promising clinical pathways."
      },
      "long_term_outlook": {
        "citation_ids": [
          "[1]",
          "[8]"
        ],
        "founded_year": 1953,
        "maturity_stage": "Institution",
        "revenue_growth_3yr": -5.3,
        "room_for_funding": "MEDIUM",
        "room_for_funding_explanation": "While CRI has <cite id=\"16\">large reserves</cite>, its <cite id=\"17\">declining revenue</cite> suggests a need for new donor support to maintain its grantmaking scale.",
        "strategic_priorities": [
          "Expand clinical study funding",
          "Increase patient awareness of immunotherapy"
        ],
        "years_operating": 73
      },
      "organizational_capacity": {
        "board_size": 34,
        "ceo_compensation": 650000,
        "ceo_compensation_pct_revenue": 2.01,
        "ceo_name": "Jill O'Donnell-Tormey",
        "citation_ids": [
          "[7]",
          "[8]"
        ],
        "employees_count": 45,
        "geographic_reach": "Global (USA, Sweden, Worldwide)",
        "has_conflict_policy": true,
        "has_financial_audit": true,
        "independent_board_pct": 1,
        "payroll_to_revenue_pct": 18.5,
        "programs_count": 5,
        "staff_per_million_revenue": 1.4,
        "volunteers_count": 0
      },
      "peer_comparison": {
        "citation_ids": [
          "[5]",
          "[21]"
        ],
        "differentiator": "CRI's <cite id=\"5\">84.0% program ratio</cite> is lower than the <cite id=\"21\">peer median of 84.6%</cite>, though its financial health score is superior.",
        "peer_group": "Global Health Research",
        "similar_orgs": [
          "Fight Colorectal Cancer",
          "Against Malaria Foundation",
          "Helen Keller International"
        ]
      },
      "similar_organizations": [
        {
          "differentiator": "Narrower disease focus",
          "name": "Fight Colorectal Cancer"
        },
        {
          "differentiator": "Direct intervention vs research",
          "name": "Against Malaria Foundation"
        },
        {
          "differentiator": "Broader medical service delivery",
          "name": "Helen Keller International"
        }
      ],
      "strengths": [
        {
          "citation_ids": [
            "[4]",
            "[7]"
          ],
          "detail": "CRI maintains a <cite id=\"4\">perfect 100.0/100 from Charity Navigator</cite>, reflecting top-tier transparency and governance standards.",
          "point": "Exceptional Financial Accountability"
        },
        {
          "citation_ids": [
            "[7]",
            "[11]"
          ],
          "detail": "The organization demonstrates lean operations, spending only <cite id=\"11\">$0.11 to raise every $1</cite> in charitable contributions.",
          "point": "High Fundraising Efficiency"
        },
        {
          "citation_ids": [
            "[8]",
            "[12]"
          ],
          "detail": "CRI funds research worldwide, including <cite id=\"12\">$6,979,372 in foreign grants</cite> to support international clinical and laboratory integration.",
          "point": "Global Research Impact"
        }
      ],
      "strengths_deep_dive": [
        "The Cancer Research Institute's impact is rooted in its ability to catalyze systemic change within the medical field. By funding <cite id=\"13\">33 domestic recipients</cite> and 11 foreign partners, CRI ensures that immunotherapy research is a global endeavor. Their <cite id=\"14\">Platinum Seal of Transparency from Candid</cite> confirms their commitment to sharing outcome metrics, such as the <cite id=\"15\">increase in immunotherapy usage since 2011</cite>. Furthermore, the organization maintains a robust <cite id=\"16\">working capital ratio of 21.2 months</cite>, ensuring long-term stability for multi-year research fellowships."
      ],
      "summary": "The Cancer Research Institute (CRI) is a pioneering global nonprofit that has been at the forefront of oncology since its <cite id=\"1\">founding in 1953</cite>. Dedicated to harnessing the power of the immune system to conquer all forms of cancer, CRI operates as a strategic funder of <cite id=\"2\">innovative phase I/II clinical studies</cite> and postdoctoral fellowships. The organization reported <cite id=\"3\">total revenue of $32,295,259</cite> in its most recent fiscal year, maintaining a <cite id=\"4\">perfect 100/100 overall score from Charity Navigator</cite>. This financial health is underscored by a <cite id=\"5\">program expense ratio of 84.0%</cite>, with the majority of funds directed toward high-impact research initiatives like the <cite id=\"6\">Lloyd J. Old STARs Program and Irvington Postdoctoral Fellowships</cite>. CRI's systemic approach to change is evidenced by its role in the <cite id=\"7\">20 FDA immunotherapy approvals in 2024</cite>, reflecting a commitment to long-term medical breakthroughs rather than immediate direct service. As a <cite id=\"8\">significant grantmaker</cite>, CRI distributed <cite id=\"9\">$22,755,861 in total grants</cite> to leading institutions, including the <cite id=\"10\">University of Pennsylvania and Yale University School of Medicine</cite>.",
      "zakat_guidance": {
        "classification": null,
        "eligibility": "SADAQAH-ELIGIBLE"
      }
    }
  }
}